GOLPH3 and gastric cancer: Interestingly, the rates of high GOLPH3 expression were 75.00% (60 out of 80) in gastric cancer tissues, 43.75% (35 out of 80) in carcinoma-adjacent tissues and 12.50% (10 out of 80) in normal tissues, respectively (Table 5).